News

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.
Medical experts are strongly emphasizing the importance of getting vaccinated against the flu this year. The goal is to prevent ... the vehicle and able to open their car door to receive the ...
On Wednesday, as news broke that the Trump administration was reneging on the contract, Moderna reported positive results from an early trial of a vaccine targeting H5 influenza viruses. In a ...
The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to ...
Reuters reports. Despite the promising results of Moderna’s pre-pandemic influenza vaccine’s effectiveness in a Phase 1/2 clinical study, the cancellation of the program sows “uncertainty ...
has decided to terminate its award for late-stage development and the right to purchase pre-pandemic influenza vaccines. This unexpected move introduces uncertainty for the program’s future.
The interim results focus on a vaccine candidate targeting the H5 avian influenza virus subtype. The Company had previously expected to advance the program ... Moderna's Annual Report on Form ...